CANSINO BIOLOGICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.82 HKD | +2.51% |
|
+14.06% | -20.08% |
| 04-22 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
| 04-22 | Cansino Biologics Pneumococcal Vaccine's Phase I Trial Offers Positive Results | MT |
Chart calendar CanSino Biologics Inc.
96a7cba488ad4bcac2.sRfppkNdmnOGvNskDrLLP5iwpcRy9_opnfuCbGsbX88._1ib9AAE9kXu_vZed8C7bKndkacTjpceyZLXFh5zLKHlXo7vAhijGf_ylg~5d33919fa247513b39cc9e3944b2ed4d
Upcoming events on CanSino Biologics Inc.
Past events on CanSino Biologics Inc.
| 26/03/2024 | Q4 2023 Earnings Release |
| 29/10/2023 | Q3 2023 Earnings Release |
| 20/09/2023 07:30 | Extraordinary Shareholders Meeting |
| 30/08/2023 | Q2 2023 Earnings Release |
| 27/04/2023 | Q1 2023 Earnings Release |
| 27/03/2023 | Q4 2022 Earnings Release |
| 27/10/2022 | Q3 2022 Earnings Release |
| 25/08/2022 | Interim 2022 Earnings Release |
| 27/04/2022 | Q1 2022 Earnings Release |
| 24/03/2022 | FY 2021 Earnings Release |
| 27/10/2021 | Q3 2021 Earnings Release |
| 26/08/2021 | Interim 2021 Earnings Release |
| 28/04/2021 | Q1 2021 Earnings Release |
| 28/03/2021 | FY 2020 Earnings Release |
| 09/10/2020 07:30 | Extraordinary Shareholders Meeting |
| 29/08/2020 16:25 | Chinese Biopharmaceutical Association-USA Conference |
| 20/08/2020 | Interim 2020 Earnings Release |
| 09/07/2020 08:00 | Sachs Novel Coronavirus Investment Forum - Panel |
| 14/05/2020 | Annual General Meeting |
| 26/03/2020 | FY 2019 Earnings Release |
Past dividends on CanSino Biologics Inc.
| 12/07/2022 | Annual 0.937273 HKD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 0,00 26,1 - | 18,5 7,70 140.83% | 4 300 6 514 -33.99% | 1 035 1 073 -3.61% | 357 396 -9.75% | 858 |
|
EBITDA Million CNY | Released Forecast Spread | -178 -117 -51.12% | -369 -312 -18.37% | 2 021 2 531 -20.15% | -993 -1 104 10.03% | -1 621 -1 199 -35.15% | -159 |
|
EBIT Million CNY | Released Forecast Spread | -200 -226 11.5% | -401 -366 -9.66% | 1 941 3 237 -40.05% | -1 181 -441 -167.88% | -1 936 -1 655 -17.04% | -393 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -157 -168 6.87% | -397 -127 -213.55% | 1 937 3 197 -39.42% | -1 184 -649 -82.49% | -1 932 -1 599 -20.82% | -654 |
|
Net income Million CNY | Released Forecast Spread | -157 -168 6.87% | -397 -324 -22.5% | 1 914 3 565 -46.3% | -909 -575 -58.22% | -1 447 -1 155 -25.34% | -611 |
|
EPS CNY | Released Forecast Spread | -0,70 -0,76 7.36% | -1,72 -1,09 -58.27% | 7,74 12,8 -39.3% | -3,68 -2,10 -74.92% | -5,87 -4,67 -25.8% | -1,42 |
| Announcement Date | 27/03/20 | 25/02/21 | 25/02/22 | 27/02/23 | 23/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 1 214 2 552 -52.44% | 130 | 77,6 329 -76.39% | 181 231 -21.54% | 226 | 226 | 226 | 230 | |||||
|
EBIT Million CNY | Released Forecast Spread | 646 1 287 -49.83% | -508 260 -295.5% | |||||||||||
|
Net income Million CNY | Released Forecast Spread | -140 | -702 | -144 | ||||||||||
|
EPS CNY | Released Forecast Spread | 2,35 1,92 22.27% | 0,49 0,73 -32.45% | -1,76 -0,74 -136.73% | -0,57 | -2,84 | -0,58 | -0,33 | -0,33 | -0,33 | -0,31 | |||
| Announcement Date | 25/02/22 | 28/04/22 | 08/09/22 | 28/10/22 | 27/02/23 | 28/04/23 | 30/08/23 | 30/10/23 | 23/02/24 | - | - | - | - |
More events
Past sector events for CanSino Biologics Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 6185 Stock
- Calendar CanSino Biologics Inc.
